FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938536471> ?p ?o ?g. }

• W2938536471 abstract "T-cell acute lymphoblastic leukemia (T-ALL) is a lymphoid malignancy caused by the oncogenic transformation of immature T-cell progenitors with poor outcomes. WP1130 has shown potent activity against a variety of cancer but whether WP1130 has anti-T-ALL activity is not clear. USP24, one target of WP1130, is one of the largest deubiquitinases and its detailed mechanism is poorly understood. The aim of this study was to explore whether WP1130 could suppress T-ALL and the role of USP24 in T-ALL.Molecular docking and cellular thermal shift assay were performed to determine whether and how WP1130 directly interact with USP24. Mitochondrial transmembrane potential assay was measured via Rhodamine 123 staining. USP24 was reactivated using the deactivated CRISPR-associated protein 9 (dCas9)-synergistic activation mediator (SAM) system. The in vivo results were examined by tumor xenografts in NOD-SCID mice. All statistical analyses were performed with the SPSS software package.WP1130 treatment decreased the viability and induces apoptosis of T-ALL cells both in vitro and in vivo. Furthermore, we demonstrated that knockdown of USP24 but not USP9X could significantly induce growth inhibition and apoptosis of T-ALL cells. Oncomine database showed that USP24 expression was upregulated in T-ALL samples and Kaplan-Meier results indicated that the USP24 was negatively but USP9X was positively associated with survival in T-ALL patients. Additionally, we proposed that WP1130 directly interacts with the activity site pocket of USP24 in T-ALL cells, which leads to the decrease of its substrates Mcl-1. Mechanistically, WP1130 induces apoptosis by accelerating the collapse of mitochondrial transmembrane potential via USP24-Mcl-1 axis.Altogether, using WP1130 as a chemical probe, we demonstrate that USP24 but not USP9X is a novel target in T-ALL cells. Moreover, we uncovered that WP1130 induces apoptosis by accelerating the collapse of mitochondrial transmembrane potential via USP24-Mcl-1 axis. These results provide that USP24-Mcl-1 axis may represent a novel strategy in the treatment of T-ALL and WP1130 is a promising lead compound for developing anti-T-ALL drugs." @default.
• W2938536471 created "2019-04-25" @default.
• W2938536471 creator A5008923395 @default.
• W2938536471 creator A5010098260 @default.
• W2938536471 creator A5011233050 @default.
• W2938536471 creator A5014795319 @default.
• W2938536471 creator A5018143240 @default.
• W2938536471 creator A5020228184 @default.
• W2938536471 creator A5031738432 @default.
• W2938536471 creator A5035180635 @default.
• W2938536471 creator A5036220085 @default.
• W2938536471 creator A5052348100 @default.
• W2938536471 creator A5058048604 @default.
• W2938536471 creator A5069130770 @default.
• W2938536471 creator A5080150992 @default.
• W2938536471 creator A5084533462 @default.
• W2938536471 date "2019-03-13" @default.
• W2938536471 modified "2023-10-16" @default.
• W2938536471 title "WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia" @default.
• W2938536471 cites W1527261975 @default.
• W2938536471 cites W1888266266 @default.
• W2938536471 cites W1931365650 @default.
• W2938536471 cites W1969232124 @default.
• W2938536471 cites W1981231641 @default.
• W2938536471 cites W1991249033 @default.
• W2938536471 cites W1993251792 @default.
• W2938536471 cites W1999608828 @default.
• W2938536471 cites W2000589976 @default.
• W2938536471 cites W2014351790 @default.
• W2938536471 cites W2044293966 @default.
• W2938536471 cites W2077398861 @default.
• W2938536471 cites W2080407374 @default.
• W2938536471 cites W2087877138 @default.
• W2938536471 cites W2099370814 @default.
• W2938536471 cites W2117546563 @default.
• W2938536471 cites W2127862779 @default.
• W2938536471 cites W2134404356 @default.
• W2938536471 cites W2134779016 @default.
• W2938536471 cites W2135760276 @default.
• W2938536471 cites W2140056054 @default.
• W2938536471 cites W2147855899 @default.
• W2938536471 cites W2152921914 @default.
• W2938536471 cites W2201446594 @default.
• W2938536471 cites W2253837246 @default.
• W2938536471 cites W2337700914 @default.
• W2938536471 cites W2339658711 @default.
• W2938536471 cites W2402068897 @default.
• W2938536471 cites W2469259618 @default.
• W2938536471 cites W2515158720 @default.
• W2938536471 cites W2562139567 @default.
• W2938536471 cites W2756640516 @default.
• W2938536471 cites W2757192793 @default.
• W2938536471 cites W2795717814 @default.
• W2938536471 cites W2799653066 @default.
• W2938536471 cites W2804822363 @default.
• W2938536471 cites W2885862304 @default.
• W2938536471 cites W2888866921 @default.
• W2938536471 cites W2894002793 @default.
• W2938536471 cites W828733275 @default.
• W2938536471 doi "https://doi.org/10.1186/s12935-019-0773-6" @default.
• W2938536471 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6415346" @default.
• W2938536471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30911287" @default.
• W2938536471 hasPublicationYear "2019" @default.
• W2938536471 type Work @default.
• W2938536471 sameAs 2938536471 @default.
• W2938536471 citedByCount "17" @default.
• W2938536471 countsByYear W29385364712020 @default.
• W2938536471 countsByYear W29385364712021 @default.
• W2938536471 countsByYear W29385364712022 @default.
• W2938536471 countsByYear W29385364712023 @default.
• W2938536471 crossrefType "journal-article" @default.
• W2938536471 hasAuthorship W2938536471A5008923395 @default.
• W2938536471 hasAuthorship W2938536471A5010098260 @default.
• W2938536471 hasAuthorship W2938536471A5011233050 @default.
• W2938536471 hasAuthorship W2938536471A5014795319 @default.
• W2938536471 hasAuthorship W2938536471A5018143240 @default.
• W2938536471 hasAuthorship W2938536471A5020228184 @default.
• W2938536471 hasAuthorship W2938536471A5031738432 @default.
• W2938536471 hasAuthorship W2938536471A5035180635 @default.
• W2938536471 hasAuthorship W2938536471A5036220085 @default.
• W2938536471 hasAuthorship W2938536471A5052348100 @default.
• W2938536471 hasAuthorship W2938536471A5058048604 @default.
• W2938536471 hasAuthorship W2938536471A5069130770 @default.
• W2938536471 hasAuthorship W2938536471A5080150992 @default.
• W2938536471 hasAuthorship W2938536471A5084533462 @default.
• W2938536471 hasBestOaLocation W29385364711 @default.
• W2938536471 hasConcept C173396325 @default.
• W2938536471 hasConcept C185592680 @default.
• W2938536471 hasConcept C190283241 @default.
• W2938536471 hasConcept C207001950 @default.
• W2938536471 hasConcept C502942594 @default.
• W2938536471 hasConcept C54355233 @default.
• W2938536471 hasConcept C55493867 @default.
• W2938536471 hasConcept C86803240 @default.
• W2938536471 hasConceptScore W2938536471C173396325 @default.
• W2938536471 hasConceptScore W2938536471C185592680 @default.
• W2938536471 hasConceptScore W2938536471C190283241 @default.
• W2938536471 hasConceptScore W2938536471C207001950 @default.
• W2938536471 hasConceptScore W2938536471C502942594 @default.
• W2938536471 hasConceptScore W2938536471C54355233 @default.

• next